Phase II Palliative RT & Anti-PD-1/PD-L1 Checkpoint Blockade in Metastatic Merkel Cell Carcinoma

Condition:   Merkel Cell Carcinoma Interventions:   Drug: Pembrolizumab;   Radiation: Radiation Therapy Sponsor:   Stanford University Not yet recruiting

Source: ClinicalTrials.gov - June 17, 2019 Category: Research Source Type: clinical trials